Baxter expects to reach 100% allocation across several IV product codes by the end of 2023. The company plans to increase production capacity through phased updates in late November, mid-December and ...
On Oct. 9, the U.S. Food & Drug Administration authorized Baxter to import intravenous solution and dialysis products from sites in Canada, China, Ireland and the U.K. Airlifting in supplies is ...
Baxter International cut its annual profit forecast on Friday due to a hurricane-related hit to its intravenous solutions facility, sending its shares down 3.3% in premarket trading.